GlycoMimetics Inc (GLYC)
1.83
+0.11
(+6.40%)
USD |
NASDAQ |
May 03, 16:00
1.835
0.00 (0.00%)
After-Hours: 20:00
GlycoMimetics 1 Year Total Returns (Daily): 34.56% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 03, 2024 | 34.56% |
| May 02, 2024 | 21.99% |
| May 01, 2024 | 13.29% |
| April 30, 2024 | 28.57% |
| April 29, 2024 | 10.71% |
| April 26, 2024 | 19.71% |
| April 25, 2024 | 24.82% |
| April 24, 2024 | 32.50% |
| April 23, 2024 | 27.43% |
| April 22, 2024 | 25.00% |
| April 19, 2024 | 27.48% |
| April 18, 2024 | 44.00% |
| April 17, 2024 | 46.15% |
| April 16, 2024 | 46.26% |
| April 15, 2024 | 53.40% |
| April 12, 2024 | 67.83% |
| April 11, 2024 | 84.19% |
| April 10, 2024 | 84.21% |
| April 09, 2024 | 111.0% |
| April 08, 2024 | 103.9% |
| April 05, 2024 | 125.4% |
| April 04, 2024 | 124.0% |
| April 03, 2024 | 121.2% |
| April 02, 2024 | 134.9% |
| April 01, 2024 | 141.3% |
| Date | Value |
|---|---|
| March 28, 2024 | 114.3% |
| March 27, 2024 | 125.5% |
| March 26, 2024 | 105.0% |
| March 25, 2024 | 102.9% |
| March 22, 2024 | 112.3% |
| March 21, 2024 | 97.26% |
| March 20, 2024 | 111.8% |
| March 19, 2024 | 109.3% |
| March 18, 2024 | 100.0% |
| March 15, 2024 | 71.81% |
| March 14, 2024 | 68.39% |
| March 13, 2024 | 75.86% |
| March 12, 2024 | 100.0% |
| March 11, 2024 | 95.42% |
| March 08, 2024 | 85.71% |
| March 07, 2024 | 91.78% |
| March 06, 2024 | 95.95% |
| March 05, 2024 | 85.90% |
| March 04, 2024 | 94.87% |
| March 01, 2024 | 92.95% |
| February 29, 2024 | 87.66% |
| February 28, 2024 | 86.36% |
| February 27, 2024 | 86.42% |
| February 26, 2024 | 81.07% |
| February 23, 2024 | 69.59% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-85.41%
Minimum
Mar 18 2020
289.4%
Maximum
Feb 14 2023
-9.33%
Average
-34.92%
Median
May 30 2019
1 Year Total Returns (Daily) Benchmarks
| Altimmune Inc | 46.59% |
| Cellectar Biosciences Inc | 126.5% |
| PDS Biotechnology Corp | -39.17% |
| Syros Pharmaceuticals Inc | 71.57% |
| Precision BioSciences Inc | -57.24% |